Abstract. Microarray and comparative genomic hybridization (CGH) studies have provided a wide range of information about esophageal cancer, but the correlations between gene expression and copy number alteration are largely unknown. To identify putative amplification target genes in esophageal cancer, a survey of parallel DNA copy number and gene expression in 10 esophageal squamous cell carcinoma (ESCC) cell lines was performed using classical CGH and oligonucleotide microarrays. The gene expression and copy number data were subsequently integrated using signal-tonoise ratio analysis. The results revealed a set of 97 genes with elevated expression levels that were attributable to increased copy number. The set included genes previously reported as overexpressed in cancer as well as several novel genes associated with copy number elevation. These genes are involved in essential cellular processes (e.g., regulation of transcription, signal transduction, cell proliferation, the cell cycle and cell differentiation) that can also have an impact on cancer development. Thus, the integration of DNA and RNA profiles provides a highly productive entry point for the discovery of genes involved in the development and progression of esophageal cancer.
Introduction
The initiation and progression of human cancer is associated with the accumulation of alterations in the function of important regulatory genes. Many different factors, including changes in genome copy number, can perturb appropriate gene function. The consensus that certain genomic aberrations may involve genes that are important for tumor development (1,2) is particularly evident in cases involving changes in gene dosage; oncogene activities may be enhanced by amplification while tumor suppressor genes may be suppressed by a physical deletion (3) . However, since a copy number change does not necessarily induce actual alterations in gene expression, functional consequences of recurrent abnormalities do not always appear (4) . The issue is further complicated by the observation that many aberrations map to large chromosomal regions that contain multiple genes (1) that are not directly associated with tumor pathogenesis.
Microarray and comparative genomic hybridization (CGH) have been used to document solid tumor features. Gene expression analyses using microarrays have revealed novel candidate genes for cancer initiation, progression and malignancy in esophageal cancer (5) (6) (7) (8) (9) . In CGH analysis, the pattern of aberration, which comprises the numbers and types of aberrations and the regions that are recurrently altered, is characteristic of each tumor type. In esophageal cancer, copy number gains have been observed at 3q26.3-27, 5p15, 8q24, 11q13, 14q32, 20q13.3 and Xq27-28. while recurrent losses have been observed at 9p13 (10, 11) . The frequent amplifications and their effects on expression levels have been monitored in recent studies with CGH microarrays. For example, in work done on breast cancer cell lines, 40% of highly amplified genes were overexpressed (12) , whereas in a similar study of primary breast tumors, 62% of highly amplified genes were overexpressed (13) . A study on head and neck squamous cell carcinoma concluded that large chromosomal regions are transcriptionally affected, although many genes appeared to be unrelated to malignant progression (14) . Such studies suggest that genomic alterations can directly influence global expression patterns, and that the alterations may be selected because they alter the expression of multiple genes that coordinately promote tumor progression (1) . However, a similar work on colorectal tumors produced a different result. An analysis of the gene expression data suggested that only a small minority of amplified genes are overexpressed in colorectal tumors (4) . Putative target genes in pancreatic cancer were extracted when direct integration of CGH and microarray data, with bioinformatics analysis, was used to specifically identify those gene expression change events associated with copy number alterations (15, 16) . As for esophageal cancer, the relationship between changes in DNA content and gene expression remains to be discovered. Therefore, identification of the affected genes in these loci, In this study, we integrated CGH and expression profiling to reveal the associated copy-number-driven changes in gene expression and the effective entry points for cancer gene discovery in esophageal cancer. Analysis of 10 esophageal squamous cell carcinoma (ESCC) cell lines revealed a set of 97 genes whose expression levels were correlated with copy number increase. We hypothesize that these genes are likely to have a central role in the pathogenesis of esophageal cancer.
Materials and methods
Cell lines. Ten of the esophageal squamous cell carcinomas (TE1, TE2, TE3, TE10, TE13, TTn, YES1, YES2, YES4 and YES6) were generous gifts from Dr H. Shimada (Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Japan) (17) . All of the cell lines were maintained in RPMI-1640 (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT). These cells were cultured in 5% CO 2 at 37˚C.
CGH analysis DNA isolation. Chromosomal DNA was isolated from the 10 cell lines using FlexiGene (Qiagen, Hilgen, Germany), according to the manufacturer's protocol. The purity and molecular weight of the DNA were estimated using agarose gels.
Labeling, hybridization and image analysis. CGH was performed as previously described (18) . Briefly, the DNA from each cell lines was directly labeled with SpectrumGreendUTP (Vysis Inc., Downers Grove, IL) using a CGH nick translation kit (Vysis). Normal sex-matched reference DNA was labeled with SpectrumRed-dUTP (Vysis). Labeled cell line and reference DNAs, together with 10 μg of Cot-1 DNA, were denatured and hybridized to metaphase spreads that were prepared using standard protocol. The slides were washed and counterstained with DAPI. On the basis of these findings, the cut-off values were set at 1.3 and 0.7 with a 95% confidence limit.
Microarray analysis
Total-RNA isolation. Total-RNA was extracted by using TRIzol reagent (Invitrogen) following the manufacturer's protocol. RNA integrity was checked with the RNA 6000 Nano Assay kit and the 2100 Bioanalyzer (Agilent, Palo Alto, CA).
Labeling, hybridization and image analysis. The AceGene Human Oligo Chip 30K (DNA Chip Research Inc. and Hitachi Software Engineering, Yokohama, Japan) oligonucleotide microarray, which contained a total of 30,336 spots corresponding to 29,640 independent genes (the gene list is available at http://bio.hitachi-sk.co.jp/acegene/), was used for expression profiling. One microgram of total-RNA was used in each RNA amplification. Amino allyl-labeled antisense RNA was prepared with the Amino Allyl MessageAmp aRNA kit (Ambion, Austin, TX). Each aRNA from the 10 samples was labeled with Cyanine 5, whereas aRNA from Universal Reference Total-RNA (Clontech, Mountain View, CA) was labeled with Cyanine 3 as a control. Five micrograms of labeled aRNA was usually sufficient for one hybridization experiment. Probe purification, hybridization, and washings were performed according to the manufacturer's instructions. The arrays were scanned using the Packard GSI Lumonics ScanArray 4000 (Perkin-Elmer, Boston, MA). The data were analyzed by DNASIS array software (Hitachi Software Engineering, Yokohama, Japan), which converted the signal intensity of each spot into text format.
Data analysis. Log 2 -ratios of the median subtracted background intensity levels were analyzed. Data from each microarray were normalized by global normalization.
Generation of the gene list. One-sample t-tests were used to identify genes that were different at the p<0.01 level with at least a 2-fold change in expression level.
Statistical analysis. The influence of genome aberrations on gene expression levels was evaluated as previously described (12, 15, 16) . Briefly, microarray log-ratios in each cell line were z-transformed. The CGH data were represented by a vector that was labeled '1' for gain ratio >1.3 and '0' for no gain. The relation between CGH and microarray data was integrated by signal-to-noise ratio statistics (12, 15, 16) . For the analysis, the regions of gain detected in five or more cell lines were used. A weight ω was calculated for each gene: ω = (m 1 -m 0 )/(δ 1 -δ 0 ); where m 1 , δ 1 and m 0 , δ 0 denote the means and standard deviations of the expression levels in amplified and non-amplified cell lines, respectively. To assess the statistical significance of each weight, 10,000 random permutations of the label vector were performed. The probability that a gene had an equal or greater weight than the original weight by random permutation was denoted by α. A low α (<0.05) indicates a strong association between gene expression and chromosomal gain.
Gene functions. Gene functions were analyzed using PathwayAssist software (Ariadne Genomics, Rockville, MD). Functional characteristics of genes were annotated by searching for connections of genes with common regulators and finding the shortest paths between nodes.
Quantitative PCR (QPCR)
Genomic DNA. Primers were designed to amplify products of 100-200 bp within target and control sequences. Primers for control sequences in each cell line were designed within a region of euploid copy number as shown by CGH analysis. QPCR was performed by monitoring the increase in fluorescence of SYBR green dye (Qiagen) with an ABI7700 (Applied Biosystems, Foster City, CA). The relative genome aberration was calculated by the comparative C t method. The threshold value of correlation coefficient with microarray data was designated 0.8 or more.
Total-RNA. cDNA of the 10 cell lines was synthesized using QuantiTect Reverse Transcription kit (Qiagen). The measurement of gene expression was performed as described above.
Results

Genomic profiling of ESCC cell lines by chromosomal CGH.
To produce a comprehensive survey of genomic aberrations in ESCC, 10 cell lines were analyzed using classical CGH for patterns of chromosomal gains and/or losses. Many of these genome alterations were observed in all cell lines (Fig. 1 ). A region with over-representation in five or more cell lines was designated a 'gain region', and an under-represented region as a 'loss region'. Gain and loss regions are summarized in Table I . Gain regions were found at 8q23-24 (9/10 cell lines), 11q13 (9/10), 5p15.3 (8/10), 5p15.2-12 (7/10), 7p22 (7/10), 20q11.2-12 (7/10), 20q13.3 (7/10), 8q22 (6/10), 8q24.2 (6/10), 11q12 (6/10), 11q14 (6/10), 14q13-24 (6/10), 20q13.2 (6/10), 5q11.2 (5/10), 7p21 (5/10), 16q23-24 (5/10) and 20q13.1(5/10). Loss regions were found at 9q13 (8/10), 9q21 (7/10) and 18q22 (5/10).
Integration of genomic copy number and expression profile data. Expression levels in the 10 ESCC cell lines were analyzed using an oligonucleotide DNA microarray. The result of one-sample t-test analysis (p<0.01) led to the extraction of 767 genes, of which 631 were significantly overexpressed and 136 were underexpressed (data not shown).
Gene expression levels were then correlated with increased or decreased copy number by integrating gene expression and CGH data in each ESCC cell line using signal-to-noise ratio analysis. Only the gain regions on chromosomes 1-22 were used because resolution of DNA copy number losses by classical CGH is relatively unreliable. This analysis revealed significant correlations in 97 genes between gene expression and DNA copy number (Table II, p<0 .05). The average expression log-ratio of the 97 genes was 0.548, which was higher than the average of all of the genes (0.096) (p<0.001, Student's t-test).
In Table III , the 97 genes were sorted by ω value. Top ranked genes were located at 11q12-14, indicating that genes located at 11q may be significant. Thus, to verify our approach, the status of 24 genes located at 11q12-14 was confirmed using QPCR. Analysis of the Pearson's correlation coefficients between microarray and QPCR data showed that the correlations of 21 genes (88%) were significant (Table IV) . Gene copy number at 11q12-14 was also validated by genomic QPCR, and 16 genes (67%) were consistent with the CGH data.
The 97 genes and their loci are summarized in Table V . The genes and the loci were collected for each chromosome. Statistically significant genes were located with high probability at 20q11.2-13.3 (29/97 genes), 11q12-14 (24/97), and 14q13-24 (20/97). Conversely, genes with scarce transcripts were located at 16q23-24 and 7p22-21.
Obtaining the functional characteristics of the genes. The possible roles of the 97 genes in the pathogenesis of esophageal cancer were investigated using text-mining to annotate functional characteristics. A large fraction (49%) of the 47 genes was involved in key cellular processes including regulation of transcription, signal transduction, cell proliferation, Under-representations (50% or more) were found at 9q13, 9q21 and 18q22. Gains and losses were defined by log 2 -ratios of >1.3 and <0.7, respectively. Table I . Highly alternated loci in ESCC. 
Gains and losses were defined by log 2 -ratios of >1.3 and <0.7, respectively. Table II . List of overexpressed genes with statistically significant correlation (p<0.05) between gene copy number and expression ratios. ----------------------------------------------------------------------------------------------------- cell cycle, and cell differentiation. The remaining 50 (51%) genes were novel and represented hypothetical proteins or known genes with no functional annotation.
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Discussion
Esophageal cancer is a highly aggressive neoplasm. On a global basis, esophageal cancer is the sixth leading cause of cancer deaths. Gastric and esophageal cancers together accounted for nearly 1.3 million new cases and 980,000 deaths worldwide in 2,000, more than lung, breast or colorectal cancer (19) . New methods for early detection, a better understanding of the biological mechanisms underlying cancer progression, and novel cancer-targeted treatments are urgently needed to reduce the mortality from this lethal disease.
The availability of global expression and genome aberration platforms, such as microarrays and CGH, has greatly facilitated the identification of novel tumor markers in many cancer types. The main focus of this study was to identify genes whose overexpression could be correlated with an increase in DNA copy number. Chromosomal alterations were first determined by performing CGH. Subsequent expression analysis using 30,336-spot microarrays permitted direct correlation between copy number and expression level on a gene-by-gene basis.
In this study, CGH analysis revealed altered loci (i.e., gain and loss regions) in the ESCC cell lines. The gain regions were located at 8q23-24, 11q13, 5p15.3, 5p15.2-12, 7p22, 20q11.2-12, 20q13.3, 8q22, 8q24.2, 11q12, 11q14, 14q13-24, 20q13.2, 5q11.2, 7p21, 16q23-24 and 20q13.1; the loss regions were found at 9q13, 9q21 and 18q22. The regions reported here match the region described in the published literature (10, 11, 20) . These regions are also characteristic of other squamous cell carcinomas (head and neck, cervical, anal and oral carcinoma) and columnar epithelium (10) .
Expression analysis of the 10 ESCC cell lines using oligonucleotide DNA microarrays extracted 767 genes with significantly altered expression profiles. Of these genes, 631 were overexpressed and 136 were under-expressed. Some of these genes have also exhibited altered expression profiles in esophageal cancer (e.g., CDC2, ID1, keratin, laminin, vimentin, insulin-like growth factor binding protein and S100 calcium binding protein) (5, (7) (8) (9) 21) . Other studies have shown that it is possible to use gene expression microarrray data not only to identify characteristic genes that are associated with cancer development (7, 22, 23) , but also to detect cytogenetic changes (24) .
CGH and expression profiling data were integrated to evaluate copy-number-driven changes in gene expression. The integration of microarray data with CGH permits more relevant interpretations of the expression data by highlighting the dependence of gene expression on gene dosage. To facilitate the identification of possible amplification target genes, we applied a statistical approach, signal to noise ratio analysis, to investigate the effects of gene copy number on gene expression levels across all 10 cell lines (15, 16) . Only the gain regions were used for this analysis because resolution of DNA copy number losses by classical CGH is relatively unreliable.
Several previous studies have reported that chromosome 11 abnormalities are frequently found in esophageal cancer Table III . A subset of which shows statistically significant genes grouped by each chromosome. - Table IV . Verification of expression and DNA copy number data by QPCR. 
10), suggesting that oncogenes or genes which are involved in this locus are related to the initiation and/or progression of this cancer (10, (25) (26) (27) . QPCR analysis of 24 genes at 11q12-14 was used to verify microarray and CGH data. The Pearson's correlation coefficients between the microarray and QPCR data were high, with the correlations of 21 genes above 0.8 (Table IV) . Validation of the copy number of these genes by genomic QPCR produced 16 genes that corresponded to the CGH data. These results strongly support the reliability and rationale of our approach. The confirmation rates between CGH and genomic QPCR might be low due to the possibly low resolution of CGH data.
Although gene copy number has been shown to be a major determinant of gene expression level, there are genes whose elevated expression levels are not correlated with increases in gene copy number (12) . It was, therefore, expected that this statistical approach would identify an overlapping, but clearly separate, set of genes than those reported in studies where only expression levels were evaluated. This observation might be attributed to the multiple mechanisms responsible for normal and abnormal control of gene expression, including those related to mutation, promoter methylation and micro-RNA expression.
This systematic analysis identified 97 genes, including novel genes as well as previously described oncogenes, such as RAB6A, MEN1, CSE1L, DNCL2A, GNAS, NEU3, NSUN2, PC4, PFDN4, PPFIA1, RPS21, SERRPINH1, SRF54, STARD10, UBE2C and ZNF217. RAB6A is a known member of the RAS oncogene family; CSE1L plays a role in the mitotic spindle checkpoint, which assures genomic stability during cell division (28) ; and PC4 mediates enhancement of p53 DNA binding as a transcriptional coactivator (29) . However, most of the genes identified by the statistical approach in this study are novel for esophageal cancer. These genes are expected to be related to the pathogenesis of this disease. An attempt to elucidate some of their functions using pathway analysis has not yielded significant results (data not shown).
Although this study was restricted to the gain regions, it is well accepted that DNA copy number aberrations owing to deletions and low-level gains are also of great importance in cancer pathology. Therefore, the analysis of copy number aberration is used at the gain regions, even though quantitative data for a single case might also be important in deciphering tumor-maintaining cancer gene networks.
In conclusion, the use of CGH, bioinformatics tools, and integration of expression profiles, led to the identification of genes with overexpression profiles that are associated with an alteration in DNA copy number in esophageal cancer. The high degree of genomic complexity, the recurrent nature of these lesions, and preliminary functional characterization of resident genes support the view that a large number of important oncogenes and tumor suppressor genes remain to be identified, opening potential therapeutic and diagnostic opportunities for this disease. Table V . Functional characteristics of the statistical significant genes. Regulation of transcription  12  BTBD4, CHURC1, ETV1, GMEB2, MED6, MEN1, PC4, PRKCBP1,  SNAPC1, SSRP1, ZHX1, ZNF217  Signal transduction  9  CFL1, GNAS, LTBP2, MS4A7, PDE2A, PPAP2A, 
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